Rayan Mallat-Khaddaj
Calgary, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Administration of the KCa channel activator SKA-31 improves long-term endothelial function, blood pressure regulation and cardiac performance in rats with type 2 diabetes.
Journal: Metabolism: clinical and experimental
Published: June 09, 2025
Administration of the KCa channel activator SKA-31 improves endothelial function in the aorta of atherosclerosis-prone mice.
Journal: Frontiers in pharmacology
Published: December 13, 2024
SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
Journal: Neurobiology of disease
Published: June 15, 2021
Pharmacological Targeting of KCa Channels to Improve Endothelial Function in the Spontaneously Hypertensive Rat.
Journal: International journal of molecular sciences
Published: June 17, 2019
SKA-31, an activator of Ca2+-activated K+ channels, improves cardiovascular function in aging.
Journal: Pharmacological research
Published: April 25, 2019
Pharmacologic targeting of endothelial Ca2+-activated K+ channels: A strategy to improve cardiovascular function.
Journal: Channels (Austin, Tex.)
Published: March 27, 2018
SKA-31, an activator of endothelial Ca2+-activated K+ channels evokes robust vasodilation in rat mesenteric arteries.
Journal: European journal of pharmacology
Published: January 31, 2018
The vascular endothelium: A regulator of arterial tone and interface for the immune system.
Journal: Critical reviews in clinical laboratory sciences
Published: November 01, 2017
Novel n-3 PUFA monoacylglycerides of pharmacological and medicinal interest: Anti-inflammatory and anti-proliferative effects.
Journal: European journal of pharmacology
Published: June 30, 2016
Pro-Resolving Effects of Resolvin D2 in LTD4 and TNF-α Pre-Treated Human Bronchi.
Journal: PloS one
Published: June 13, 2016
MAG-DPA curbs inflammatory biomarkers and pharmacological reactivity in cytokine-triggered hyperresponsive airway models.
Journal: Pharmacology research & perspectives
Published: January 25, 2016
Reversal of IL-13-induced inflammation and Ca(2+) sensitivity by resolvin and MAG-DHA in association with ASA in human bronchi.
Journal: Prostaglandins & other lipid mediators
Published: September 23, 2014
Last Updated: 09/26/2026